NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Aestus Therapeutics, Inc. (Aestus; North Brunswick, NJ) announced today a collaboration agreement with Eisai Inc. (Eisai; Woodcliff Lake, NJ) on research and development of novel therapeutics for the treatment of psychiatric disorders. The multi-year collaboration will entail pre-clinical validation of potential therapeutics leading to clinical proof-of-concept studies.
